サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683393

泌尿器ロボット機器の世界市場：2025年～2033年

Global Urology Robotics Devices Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
泌尿器ロボット機器の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の泌尿器ロボット機器の市場規模は、2024年に67億2,000万米ドルに達し、2033年には285億7,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは17.7%となる見込みです。

泌尿器ロボット機器は、膀胱、腎臓、前立腺、その他の関連臓器を含む泌尿器系に対する低侵襲手技を行う際に外科医を支援するために使用される高度な手術ツールです。これらの機器は通常、特殊な器具を装備したロボットアーム、可視化を強化する高解像度3Dカメラ、および外科医がシステムを正確に制御できるコンソールで構成されています。

これらの装置により、切開創の縮小、回復時間の短縮、出血量の減少、傷跡の最小化が可能になり、繊細な泌尿器科手術において高い精度を維持しながら患者の転帰を改善することができます。

技術の進歩は、泌尿器科手術の精度、効率、成果を向上させることで、泌尿器ロボット機器市場を大きく牽引しています。より優れた視覚化、低侵襲技術、リアルタイムのデータ分析を提供する強化されたロボットシステムのような技術革新により、外科医はより高い精度と制御で複雑な手技を行うことができます。こうした進歩により、患者の回復時間が短縮され、合併症が最小限に抑えられ、全体的な手術成績が向上するため、ロボット機器は泌尿器科でますます人気の選択肢となっています。例えば、2024年9月には、泌尿器ロボット機器市場における画期的な進歩が発表されました。ロボットエナジーベースの治療における世界的リーダーであるEDAP TMS SAと、AIヘルスケアの主要企業であるAvenda Healthが、前立腺がん治療に革命を起こすための提携契約を締結したのです。Avendaの革新的AI技術であるアンフォールドAIをEDAP TMSの最先端ロボット高強度焦点式超音波（HIFU）システムFocal Oneと統合することで、両社は世界初のAI支援ロボットHIFU施術を開始します。

さらに、これらの機器に人工知能と機械学習を統合することで、個人に合わせた治療計画が可能になり、泌尿器科治療におけるロボット技術の採用をさらに後押しします。その結果、泌尿器科用ロボット機器の需要は急速に伸びており、市場の拡大と技術的躍進につながっています。

医療機器、特にロボットシステムの承認プロセスは複雑で時間がかかり、多くの場合、大規模な臨床試験、安全性評価、地域基準や国際基準への準拠が求められます。そのため、製品上市の遅れや開発コストの増加につながる可能性があります。その結果、このような規制は市場の拡大を遅らせ、泌尿器科における新しい最先端のロボット技術の利用可能性を全体的に低下させる可能性があります。

当レポートでは、世界の泌尿器ロボット機器市場について調査し、市場の概要とともに、製品タイプ別、手技別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第5章 業界分析

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 製品タイプ別

  • ロボット手術システム
  • 機器とアクセサリ
  • その他

第7章 手技別

  • ロボットによる前立腺切除術
  • ロボットによる膀胱切除術
  • ロボットによる腎盂形成術
  • ロボットによる腎摘出

第8章 エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢

第11章 企業プロファイル

  • Intuitive Surgical
  • Asensus Surgical US, Inc.
  • MicroPort Scientific Corporation
  • Titan Medical Inc.
  • Ethicon, Inc.
  • Medtronic
  • CMR Surgical Ltd

第12章 付録

目次
Product Code: MD9342

The global urology robotics devices market reached US$ 6.72 billion in 2024 and is expected to reach US$ 28.57 billion by 2033, growing at a CAGR of 17.7% during the forecast period 2025-2033.

Urology robotic devices are advanced surgical tools used to assist surgeons in performing minimally invasive procedures on the urinary system, including the bladder, kidneys, prostate, and other related organs. These devices typically consist of robotic arms equipped with specialized instruments, a high-definition 3D camera for enhanced visualization, and a console where the surgeon can control the system with precision.

These devices allow for smaller incisions, faster recovery times, reduced blood loss, and minimal scarring, improving patient outcomes while maintaining high levels of precision in delicate urological surgeries.

Market Dynamics: Drivers & Restraints

Technological Advancements

Technological advancements are significantly driving the urology robotic devices market by improving the precision, efficiency, and outcomes of urological procedures. With innovations like enhanced robotic systems offering better visualization, minimally invasive techniques, and real-time data analytics, surgeons can perform complex procedures with greater accuracy and control. These advancements reduce patient recovery times, minimize complications, and improve overall surgical outcomes, making robotic devices an increasingly popular choice in urology. For instance, in September 2024, A groundbreaking advancement in the urology robotic devices market was announced as EDAP TMS SA, a global leader in robotic energy-based therapies, and Avenda Health, a leading AI healthcare company, have entered into a collaboration agreement to revolutionize prostate cancer care. By integrating Avenda's innovative AI technology, Unfold AI, with EDAP TMS's cutting-edge Focal One robotic high-intensity focused ultrasound (HIFU) system, the companies are set to launch the world's first AI-assisted robotic HIFU procedures.

Additionally, the integration of artificial intelligence and machine learning in these devices allows for personalized treatment plans, further boosting the adoption of robotic technologies in urological care. As a result, the demand for urology robotic devices is rapidly growing, leading to market expansion and technological breakthroughs.

Stringent Regulatory Frameworks

The approval process for medical devices, especially robotic systems, is complex and time-consuming, often requiring extensive clinical trials, safety evaluations, and compliance with regional and international standards. This can lead to delays in product launches and increased development costs. As a result, these regulations can slow market expansion and reduce the overall availability of new, cutting-edge robotic technologies in urology.

Segment Analysis

The global urology robotics devices market is segmented based on the product type, procedure, end-user and region.

Robotic surgery systems segment in the product type is expected to dominate the urology robotics devices market

The robotic surgery systems segment is dominating the urology robotic devices market due to several key factors. Robotic surgery systems offer significant advantages in precision, control, and minimally invasive procedures, which are crucial for complex urological surgeries. These systems allow for enhanced visualization, reduced risk of human error, and quicker recovery times for patients, making them highly attractive to healthcare providers.

As the technology continues to evolve, robotic surgery systems are becoming more sophisticated, offering better outcomes and driving higher adoption rates across hospitals and surgical centers. For instance, in July 2024, Asensus Surgical, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an expanded indication to treat both adult and pediatric urology patients with the Senhance Surgical System. This expansion highlights the growing dominance of the robotic surgery systems segment, as the Senhance system's advanced technology enables more precise, minimally invasive procedures in urology. Thus, the above factors are expected to hold the segment in the dominant position.

Geographical Analysis

North America is expected to dominate the urology robotics devices market

North America is dominating the urology robotic devices market due to several key factors. The region has a strong healthcare infrastructure with advanced medical facilities and a high adoption rate of cutting-edge technologies, including robotic surgery systems. Hospitals and surgical centers in North America are more likely to invest in expensive robotic systems due to their ability to improve patient outcomes, reduce recovery times, and minimize surgical complications.

Furthermore, North America has a well-established reimbursement structure for robotic surgeries, making it financially feasible for healthcare providers to adopt these technologies. Companies are receiving FDA approvals for their advanced innovations which are driving the region's market growth.

For instance, in July 2024, Asensus Surgical, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indication of its Senhance Surgical System to treat both adult and pediatric urology patients. This approval reflects the region's continuous innovation and adoption of advanced medical technologies, positioning North America at the forefront of robotic-assisted surgery. North America remains a global leader in transforming healthcare through robotics, setting new standards for precision, efficiency, and patient outcomes in urological care. The region also benefits from a large, aging population with an increasing demand for urological procedures, further fueling the growth of robotic devices.

Competitive Landscape

The global market players in the urology robotics devices market are Intuitive Surgical, Asensus Surgical US, Inc., MicroPort Scientific Corporation, Titan Medical Inc., Ethicon, Inc., Medtronic and CMR Surgical Ltd., among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global urology robotics devices market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Procedure
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancements in Technology
      • 4.1.1.2. Increasing Prevalence of Urological Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Frameworks
      • 4.1.2.2. Limited Availability of Trained Professionals
    • 4.1.3. Opportunities
      • 4.1.3.1. Strategic Partnerships and Collaborations
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Robotic Surgery Systems*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Instruments and Accessories
  • 6.4. Others

7. By Procedure

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Robotic Prostatectomy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Robotic Cystectomy
  • 7.4. Robotic Pyeloplasty
  • 7.5. Robotic Nephrectomy

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Mexico
      • 9.4.6.2. Brazil
      • 9.4.6.3. Argentina
      • 9.4.6.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Intuitive Surgical*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Asensus Surgical US, Inc.
  • 11.3. MicroPort Scientific Corporation
  • 11.4. Titan Medical Inc.
  • 11.5. Ethicon, Inc.
  • 11.6. Medtronic
  • 11.7. CMR Surgical Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us